Batch and compounding records
Execute compounding with step-level documentation, ingredient tracking, pharmacist review, and electronic review signatures.
503B outsourcing facilities
Compliance operations software for 503B outsourcing facilities
A 503B facility answers to cGMP expectations: documented batch execution, a monitored environment, calibrated equipment, controlled procedures, and a deviation and CAPA program with real follow-through. CompliRx provides the operational record system underneath those expectations.
Batch documentation assembled from paper travelers and spreadsheets
Environmental monitoring data reviewed retrospectively instead of continuously
Calibration and maintenance evidence tracked per instrument, not per program
Deviations closed without connected evidence or effectiveness review
503B outsourcing facilities: supported workflows
Environmental monitoring program
Run continuous room monitoring plus viable air, surface, and personnel sampling with trending, excursion handling, and investigations.
Equipment and calibration
Track calibration schedules, certificates, maintenance, and certification records with due-date visibility across the facility.
Quality system records
Control SOPs and documents, manage deviations and CAPA with owners and effectiveness checks, and retrieve evidence quickly during FDA inspection.
What facilities gain
- Batch history retrievable with attribution and review signatures
- A monitoring program with documented follow-through
- Calibration status visible before it becomes a finding
- Deviation-to-CAPA traceability for quality review
Evaluate the batch evidence and the surrounding quality system
Before selecting software, walk through an actual batch-review scenario: ingredient evidence, required tasks, sample status, equipment records and the deviation that could affect disposition.
- Connect batch checklist items, ingredient lots and certificates of analysis to the compounding record.
- Review associated sample results, pending incubation, equipment certificates and exceptions.
- Retrieve controlled procedures, signatures and investigation follow-up for quality-unit review; agree on validation and release responsibilities before implementation.
FDA states that 503B outsourcing facilities remain subject to CGMP and have registration, product-reporting and adverse-event obligations. CompliRx supports operational records; this page does not claim FDA approval, turnkey validation or coverage of every regulatory submission.
Primary references: FDA: Information for Outsourcing Facilities · 21 CFR 211.192: Production record review · FDA: Part 11 scope and application guidance
503B outsourcing facilities: common questions
How is 503B different from a traditional 503A pharmacy?
503B is an outsourcing-facility pathway with FDA registration and CGMP obligations. Qualifying 503A compounding has different statutory conditions. Software selection should start with the facility’s actual operating model, not a shared USP checklist alone.
Is using electronic signatures sufficient for Part 11?
No. Applicability, intended use, validation, access controls, procedures and record retention need evaluation. Review the configured system and supporting evidence with your quality team; an electronic-signature feature is not an FDA certification.
Related compliance workflows
Run CompliRx for $399/month.
The 90-day pilot includes guided onboarding and configuration around how your facility actually operates.